A phase III, randomized, open-label study of ASP8273 versus erlotinib or gefitinib in patients with advanced stage IIIB/IV non-small-cell lung cancer
Author:
Funder
Astellas Pharma
Inc.
Astellas
Bristol-Myers Squibb
Eli Lilly
AstraZeneca
Novartis
Gritstone Oncology
Genentech
Xcovery
Merck
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/advance-article-pdf/doi/10.1093/annonc/mdz128/28937538/mdz128.pdf
Reference17 articles.
1. Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trials;Bell;JCO,2005
2. Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond;Ladanyi;Mod Pathol,2008
3. Lung cancer;Herbst;N Engl J Med,2008
4. Lung cancer: are we up to the challenge?;Esposito;Curr Genomics,2010
5. Epidermal growth factor receptor tyrosine kinase inhibitor-resistant disease;Ohashi;JCO,2013
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting the EGFR/RAS/RAF signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020–2023);Expert Opinion on Therapeutic Patents;2024-02
2. Leucine Zipper Downregulated in Cancer-1 Interacts with Clathrin Adaptors to Control Epidermal Growth Factor Receptor (EGFR) Internalization and Gefitinib Response in EGFR-Mutated Non-Small Cell Lung Cancer;International Journal of Molecular Sciences;2024-01-23
3. Research Advances of Small Molecule EGFR-TKIs in NSCLC;Pharmacy Information;2024
4. The advance of the third‑generation EGFR‑TKI in the treatment of non‑small cell lung cancer (Review);Oncology Reports;2023-12-05
5. Resistance of Lung Cancer to EGFR-Specific Kinase Inhibitors: Activation of Bypass Pathways and Endogenous Mutators;Cancers;2023-10-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3